Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Med Chem Lett
2010 Oct 08;21:39-42. doi: 10.1021/ml1001954.
Show Gene links
Show Anatomy links
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.
Fass DM, Shah R, Ghosh B, Hennig K, Norton S, Zhao WN, Reis SA, Klein PS, Mazitschek R, Maglathlin RL, Lewis TA, Haggarty SJ.
???displayArticle.abstract???
Carboxylic acids with known central nervous system and histone deacetylase (HDAC) inhibitory activities were converted to hydroxamic acids and tested using a suite of in vitro biochemical assays with recombinant HDAC isoforms, cell based assays in human cervical carcinoma Hela cells and primary cultures from mouse forebrain, and a whole animal (Xenopus laevis) developmental assay. Relative to the parent carboxylic acids, two of these analogs exhibited enhanced potency, and one analog showed altered HDAC isoform selectivity and in vivo activity in the Xenopus assay. We discuss potential uses of these novel hydroxamic acids in studies aimed at determining the utility of HDAC inhibitors as memory enhancers and mood stabilizers.
Bradner,
Chemical phylogenetics of histone deacetylases.
2010, Pubmed
Bradner,
Chemical phylogenetics of histone deacetylases.
2010,
Pubmed Clark,
Neurocognitive mechanisms in depression: implications for treatment.
2009,
Pubmed Dash,
Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury.
2009,
Pubmed Dickerson,
The episodic memory system: neurocircuitry and disorders.
2010,
Pubmed Eikel,
S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.
2006,
Pubmed Fischer,
Recovery of learning and memory is associated with chromatin remodelling.
2007,
Pubmed Fishbein,
Preparation and some properties of stable and carbon-14 and tritium-labeled short-chain aliphatic hydroxamic acids.
1969,
Pubmed Göttlicher,
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.
2001,
Pubmed Gurvich,
Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo.
2005,
Pubmed
,
Xenbase Gurvich,
Histone deacetylase is a target of valproic acid-mediated cellular differentiation.
2004,
Pubmed Haddad,
A review of valproate in psychiatric practice.
2009,
Pubmed Huang,
Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis.
1989,
Pubmed Hubbert,
HDAC6 is a microtubule-associated deacetylase.
2002,
Pubmed Kavanaugh,
Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma.
2010,
Pubmed Kilgore,
Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease.
2010,
Pubmed Lea,
Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs.
1999,
Pubmed Levenson,
Regulation of histone acetylation during memory formation in the hippocampus.
2004,
Pubmed Levi,
Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
1997,
Pubmed Löscher,
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
2002,
Pubmed Phiel,
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.
2001,
Pubmed
,
Xenbase Ricobaraza,
Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model.
2009,
Pubmed Skarpidi,
Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression.
2003,
Pubmed Stefanko,
Modulation of long-term memory for object recognition via HDAC inhibition.
2009,
Pubmed Tessier,
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
2009,
Pubmed Walia,
Side effects of antiepileptics--a review.
2004,
Pubmed
